Active Ingredients and Action Mechanisms of Yi Guan Jian Decoction in Chronic Hepatitis B Patients with Liver Fibrosis

BACKGROUND AND AIM: The progression of liver fibrosis in chronic hepatitis B (CHB) patients is currently insufficiently controlled worldwide. The Yi Guan Jian decoction (YGJD) has been widely used in the treatment of liver fibrosis in CHB cases. Although animal studies have reported the antifibrotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guangyao, Zhou, Yuan, Sze, Daniel Man-Yuen, Liu, Chao, Zhang, Qianru, Wang, Zihao, Yu, Hua, Chan, Ging, Wu, Zhongdao, Su, Shibing, Hu, Yuanjia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745137/
https://www.ncbi.nlm.nih.gov/pubmed/31565062
http://dx.doi.org/10.1155/2019/2408126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745137/
https://www.ncbi.nlm.nih.gov/pubmed/31565062
http://dx.doi.org/10.1155/2019/2408126

Ejemplares similares